Companies
AI toxicity & ADMET predictionconfirmed

Deep Origin

AI and simulation platform for drug discovery, including ADMET-NOW prediction models.

Notable

Leads the PREDICTS consortium under an ARPA-H CATALYST contract of up to $31.7M (Dec 2025).

Related deals

  • Dec 4, 2025
    Government funding, ARPA-H CATALYST
    PREDICTS consortium to build in silico and ex vivo models that predict drug safety and dosing before clinical trials.

Related updates

No related news yet.